2025
SJR Q1
JCR Q1 · 9,8
30 matched articles
SCIE
Journal detail
Hypertension
- Publisher
- Lippincott Williams and Wilkins
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0194911X15244563
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 3,295
- Quartile Q1
- H-Index 315
- Cites/doc 7,83
- Docs (3y) 889
- Cites (3y) 6.987
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 9,8
- 5Y JIF 9,2
- JCI 2,01
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Internal Medicine Q1
Areas
- Medicine
WoS categories
- Peripheral Vascular Diseases
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 3,295 | 9,8 | 9,2 | 2,01 | Q1 | 315 |
| 2024 | Q1 | Q1 | 2,788 | 8,2 | 8,1 | 1,88 | Q1 | 307 |
| 2023 | Q1 | Q1 | 2,827 | 7,2 | 8,5 | 1,81 | Q1 | 307 |
| 2022 | Q1 | Q1 | 2,758 | 8,3 | 9,1 | 1,64 | Q1 | 307 |
| 2021 | Q1 | Q1 | 3,395 | 9,9 | 10 | 1,89 | Q1 | 307 |
| 2020 | Q1 | Q1 | 2,986 | 10,2 | 8,8 | 1,93 | Q1 | 307 |
| 2019 | Q1 | Q1 | 2,904 | 7,7 | 7,2 | 2,01 | Q1 | 307 |
| 2018 | — | Q1 | — | 7 | 6,8 | 1,79 | Q1 | — |
| 2017 | Q1 | Q1 | 3,795 | 6,8 | 6,7 | 1,75 | Q1 | 307 |
| 2016 | Q1 | Q1 | 3,287 | 6,9 | 6,7 | — | — | 307 |
| 2015 | Q1 | Q1 | 3,722 | 6,3 | 6,9 | — | — | 307 |
| 2014 | Q1 | Q1 | 3,613 | 6,5 | 7 | — | — | 307 |
| 2013 | Q1 | Q1 | 3,843 | 7,6 | 7,3 | — | — | 307 |
| 2012 | Q1 | Q1 | 3,408 | 6,9 | 7 | — | — | 307 |
| 2011 | Q1 | Q1 | 2,675 | 6,2 | 6,6 | — | — | 307 |
| 2010 | Q1 | Q1 | 2,818 | 6,9 | 6,9 | — | — | 307 |
| 2009 | — | Q1 | — | 6,6 | 6,9 | — | — | — |
| 2008 | — | Q1 | — | 7,4 | 7,4 | — | — | — |
| 2007 | — | Q1 | — | 7,2 | 7 | — | — | — |
| 2006 | — | Q1 | — | 6 | — | — | — | — |
| 2005 | — | Q1 | — | 6,3 | — | — | — | — |
| 2004 | — | Q1 | — | 5,3 | — | — | — | — |
| 2003 | — | Q1 | — | 5,6 | — | — | — | — |
| 2002 | — | Q1 | — | 5 | — | — | — | — |
| 2001 | — | Q1 | — | 5,4 | — | — | — | — |
| 2000 | — | Q1 | — | 5,3 | — | — | — | — |
| 1999 | — | Q1 | — | 4,9 | — | — | — | — |
| 1998 | — | Q1 | — | 4,3 | — | — | — | — |
| 1997 | — | Q1 | — | 4,9 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 7/100 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 8/98 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 6/96 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 7/68 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 8/67 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 3/65 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 4/65 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 3/65 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 3/65 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 3/63 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 3/63 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 3/60 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 4/65 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 3/68 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 4/68 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 4/68 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 5/61 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 3/56 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 4/54 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 4/52 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 5/51 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 6/51 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 5/52 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 7/52 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 7/50 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 5/45 |
| 1999 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 7/44 |
| 1998 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 5/39 |
| 1997 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 4/38 |